Clinical Practice Guideline

Diagnosis and Treatment of Hyperprolactinemia

February 01, 2011

Full Guideline: Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
JCEM February 2011

Shlomo Melmed, Felipe F. Casanueva, Andrew R. Hoffman, David L. Kleinberg, Victor M. Montori, Janet A. Schlechte, John A. H. Wass

Objective:

The aim was to formulate practice guidelines for the diagnosis and treatment of hyperprolactinemia.

Introduction:

Testing for hyperprolactinemia is straightforward, owing to the ease of ordering a serum prolactin measurement. Accordingly, an evidence-based, cost-effective approach to management of this relatively common endocrine disorder is required.

Conclusions:

  • Practice guidelines are presented for diagnosis and treatment of patients with elevated prolactin levels.
  • These include:
    • evidence-based approaches to assessing the cause of hyperprolactinemia
    • treating drug-induced hyperprolactinemia
    • and managing prolactinomas in nonpregnant and pregnant subjects
  • Indications and side effects of therapeutic agents for treating prolactinomas are also presented

arrow Read the Full Guideline

On the Go

CPG Mobile App

App screen
Access guideline recommendations, patient information, and clinical education modules for a range of endocrine topics plus dozens of interactive decision algorithms and other point-of-care tools.

Download our CPG Mobile App

Access guideline recommendations, patient information, and clinical education modules for a range of endocrine topics plus dozens of interactive decision algorithms and other point-of-care tools.

Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!